Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Cell Reports|April 21, 2015
Interaction of CDCP1 with HER2 enhances HER2-driven tumorigenesis and promotes trastuzumab resistance in breast cancerAbdullah Alajati, Ilaria Guccini, Sandra Pinton, et al.
Nature Methods|April 9, 2008
Spheroid-based engineering of a human vasculature in miceAbdullah Alajati, Anna M Laib, Holger Weber, et al.
Scientific Reports|January 2, 2023
CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progressionMiriam Saponaro, Sina Flottmann, Markus Eckstein, et al.
Cancers|September 23, 2022
Androgen Receptor Splice Variants Contribute to the Upregulation of DNA Repair in Prostate CancerYuri Tolkach, Anika Kremer, Gábor Lotz, et al.
Nature Communications|December 13, 2016
Inhibition of Notch pathway arrests PTEN-deficient advanced prostate cancer by triggering p27-driven cellular senescenceAjinkya Revandkar, Maria Luna Perciato, Alberto Toso, et al.
Cancer Medicine|June 19, 2024
Preclinical evidence for the use of anti-Trop-2 antibody-drug conjugate Sacituzumab govitecan in cerebral metastasized castration-resistant prostate cancerRichard Weiten, Max Niemann, Eduard Below, et al.
Cancer Research|January 4, 2024
Adipocyte Precursor-Derived NRG1 Promotes Resistance to FGFR Inhibition in Urothelial CarcinomaSana Hosni, Viola Kilian, Niklas Klümper, et al.
Molecular Cancer Therapeutics|July 9, 2025
The Antibody-Drug Conjugate Sacituzumab Govitecan (IMMU-132) Represents a Potential Novel Therapeutic Strategy in CholangiocarcinomaRacha Hosni, Niklas Klümper, Christine Sanders, et al.
Molecular Cancer Therapeutics|June 13, 2025
The antibody-drug conjugate sacituzumab govitecan (IMMU-132) represents a potential novel therapeutic strategy in cholangiocarcinomaRacha Hosni, Niklas Klümper, Christine Sanders, et al.
Nature Communications|June 19, 2015
A chemogenomic screening identifies CK2 as a target for pro-senescence therapy in PTEN-deficient tumoursMadhuri Kalathur, Alberto Toso, Jingjing Chen, et al.
Pageof 3